Publication Cover
Journal of Dual Diagnosis
research and practice in substance abuse comorbidity
Volume 20, 2024 - Issue 3
58
Views
0
CrossRef citations to date
0
Altmetric
Psychotherapy & Psychosocial Issues

Which Factors Are Associated With Comorbid Psychiatric Conditions in Patients Affected by Substance Use Disorders? The Impact of COVID-19 Pandemic on Dual-Diagnosis Subjects

, MD, , MD, , PhDORCID Icon, , MD, , MD, , MD, , Md, , MD, , MD, , MD, , MD, , MD, , MD, , PhD & , PhD show all

References

  • Alsuhaibani, R. A., Smith, D. C., Lowrie, R., Aljhani, S., & Paudyal, V. (2021). Scope, quality and inclusivity of international clinical guidelines on mental health and substance abuse in relation to dual diagnosis, social and community outcomes: A systematic review. BMC Psychiatry, 21(1), 209. https://doi.org/10.1186/S12888-021-03188-0
  • American Psychiatric Association, DSM-5 Task Force (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (5th ed.) American Psychiatric Publishing, Inc. https://doi.org/10.1176/APPI.BOOKS.9780890425596
  • Antai-Otong, D., Theis, K., & Patrick, D. D. (2016). Dual diagnosis: Coexisting substance use disorders and psychiatric disorders. The Nursing Clinics of North America, 51(2), 237–247. https://doi.org/10.1016/J.CNUR.2016.01.007
  • Calarco, C. A., & Lobo, M. K. (2021). Depression and substance use disorders: Clinical comorbidity and shared neurobiology. International Review of Neurobiology, 157, 245–309. https://doi.org/10.1016/BS.IRN.2020.09.004
  • Caldiroli, A., Capuzzi, E., Tringali, A., Tagliabue, I., Turco, M., Fortunato, A., Sibilla, M., Montana, C., Maggioni, L., Pellicioli, C., Marcatili, M., Nava, R., Crespi, G., Colmegna, F., Buoli, M., & Clerici, M. (2022). The psychopathological impact of the SARS-CoV-2 epidemic on subjects suffering from different mental disorders: An observational retrospective study. Psychiatry Research, 307, 114334. https://doi.org/10.1016/J.PSYCHRES.2021.114334
  • Caldiroli, A., Serati, M., Orsenigo, G., Caletti, E., & Buoli, M. (2018). Age at onset and social cognitive impairment in clinically stabilized patients with schizophrenia: An ecological cross-sectional study. Iranian Journal of Psychiatry, 13(2), 84–93.
  • Chang, H.-M., Pan, C.-H., Chen, P.-H., Chen, Y.-L., Tai, M.-H., Su, S.-S., Tsai, S.-Y., Chen, C.-C., & Kuo, C.-J. (2020). Sex differences in incidence and psychiatric comorbidity for alcohol dependence in patients with panic disorder. Drug and Alcohol Dependence, 207, 107814. https://doi.org/10.1016/j.drugalcdep.2019.107814
  • Craparo, G., Faraci, P., Rotondo, G., & Gori, A. (2013). The impact of event scale - revised: Psychometric properties of the Italian version in a sample of flood victims. Neuropsychiatric Disease and Treatment, 9, 1427–1432. https://doi.org/10.2147/NDT.S51793
  • Capuzzi, E., Caldiroli, A., Besana, F., Cova, F., Buoli, M., & Clerici, M. (2020a). Factors associated with psychotic symptoms among a sample of male prisoners with substance use disorder: A cross-sectional study. Journal of Substance Abuse Treatment, 118, 108104. https://doi.org/10.1016/J.JSAT.2020.108104
  • Capuzzi, E., Di Brita, C., Caldiroli, A., Colmegna, F., Nava, R., Buoli, M., & Clerici, M. (2020b). Psychiatric emergency care during Coronavirus 2019 (COVID 19) pandemic lockdown: Results from a department of mental health and addiction of northern Italy. Psychiatry Research, 293, 113463. https://doi.org/10.1016/j.psychres.2020.113463
  • Carrà, G., Bartoli, F., Brambilla, G., Crocamo, C., & Clerici, M. (2015). Comorbid addiction and major mental illness in Europe: A narrative review. Substance Abuse, 36(1), 75–81. https://doi.org/10.1080/08897077.2014.960551
  • Castillo-Carniglia, A., Keyes, K. M., Hasin, D. S., & Cerdá, M. (2019). Psychiatric comorbidities in alcohol use disorder. The Lancet. Psychiatry, 6(12), 1068–1080. https://doi.org/10.1016/S2215-0366(19)30222-6
  • Chadwick, B., Miller, M. L., & Hurd, Y. L. (2013). Cannabis use during adolescent development: Susceptibility to psychiatric illness. Frontiers in Psychiatry, 4, 129. https://doi.org/10.3389/fpsyt.2013.00129
  • Chorlton, E., & Smith, I. C. (2016). Understanding how people with mental health difficulties experience substance use. Substance Use & Misuse, 51(3), 318–329. https://doi.org/10.3109/10826084.2015.1108341
  • Daigre, C., Grau-López, L., Palma-Alvarez, R. F., Perea-Ortueta, M., Sorribes-Puertas, M., Serrano-Pérez, P., Quesada, M., Segura, L., Coronado, M., Ramos-Quiroga, J. A., & Colom, J, & (2022). A multicenter study on the impact of gender, age, and dual diagnosis on substance consumption and mental health status in outpatients treated for substance use disorders during COVID-19 lockdown. Journal of Dual Diagnosis, 18(2), 71–80. https://doi.org/10.1080/15504263.2022.2051110
  • Daigre, C., Grau-López, L., Rodríguez-Cintas, L., Ros-Cucurull, E., Sorribes-Puertas, M., Esculies, O., Bones-Rocha, K., & Roncero, C. (2017). The role of dual diagnosis in health-related quality of life among treatment-seeking patients in Spain. Quality of Life Research: An International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation, 26(12), 3201–3209. https://doi.org/10.1007/S11136-017-1668-4
  • Daigre, C., Perea-Ortueta, M., Berenguer, M., Esculies, O., Sorribes-Puertas, M., Palma-Alvarez, R., Martínez-Luna, N., Ramos-Quiroga, J. A., & Grau-López, L. (2019). Psychiatric factors affecting recovery after a long term treatment program for substance use disorder. Psychiatry Research, 276, 283–289. https://doi.org/10.1016/j.psychres.2019.05.026
  • Degenhardt, L., & Hall, W. (2012). Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet, 379(9810), 55–70. https://doi.org/10.1016/S0140-6736(11)61138-0
  • Fantuzzi, C., & Mezzina, R. (2020). Dual diagnosis: A systematic review of the organization of community health services. The International Journal of Social Psychiatry, 66(3), 300–310. https://doi.org/10.1177/0020764019899975
  • Foster, K. T., Li, N., McClure, E. A., Sonne, S. C., & Gray, K. M. (2016). Gender differences in internalizing symptoms and suicide risk among men and women seeking treatment for cannabis use disorder from late adolescence to middle adulthood. Journal of Substance Abuse Treatment, 66, 16–22. https://doi.org/10.1016/J.JSAT.2016.01.012
  • Fuchs-Leitner, I., Yazdi, K., Gerstgrasser, N. W., Tholen, M. G., Graffius, S. T., Schorb, A., & Rosenleitner, J. (2021). Risk of PTSD due to the COVID-19 Pandemic among patients in opioid substitution treatment. Frontiers in Psychiatry, 12, 729460. https://doi.org/10.3389/fpsyt.2021.729460
  • Grau-López, L., Daigre, C., Palma-Alvarez, R. F., Sorribes-Puertas, M., Serrano-Pérez, P., Quesada-Franco, M., Segura, L., Coronado, M., Ramos-Quiroga, J. A., & Colom, J,. (2022). COVID-19 lockdown and consumption patterns among substance use disorder outpatients: A multicentre study. European Addiction Research, 28(4), 243–254. https://doi.org/10.1159/000521425
  • Guy, N., Newton-Howes, G., Ford, H., Williman, J., & Foulds, J. (2018). The prevalence of comorbid alcohol use disorder in the presence of personality disorder: Systematic review and explanatory modelling. Personality and Mental Health, 12(3), 216–228. https://doi.org/10.1002/PMH.1415
  • Harrison, J., Curtis, A., Cousins, L., & Spybrook, J. (2017). Integrated dual disorder treatment implementation in a large state sample. Community Mental Health Journal, 53(3), 358–366. https://doi.org/10.1007/S10597-016-0019-1
  • Hasin, D., & Kilcoyne, B. (2012). Comorbidity of psychiatric and substance use disorders in the United States: Current issues and findings from the NESARC. Current Opinion in Psychiatry, 25(3), 165–171. https://doi.org/10.1097/YCO.0B013E3283523DCC
  • Horowitz, M., Wilner, N., & Alvarez, W. (1979). Impact of event scale: A measure of subjective stress. Psychosomatic Medicine, 41(3), 209–218. https://doi.org/10.1097/00006842-197905000-00004
  • Hunt, G. E., Malhi, G. S., Cleary, M., Lai, H. M. X., & Sitharthan, T. (2016). Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990-2015: Systematic review and meta-analysis. Journal of Affective Disorders, 206, 331–349. https://doi.org/10.1016/J.JAD.2016.07.011
  • Iasevoli, F., Fornaro, M., D'Urso, G., Galletta, D., Casella, C., Paternoster, M., Buccelli, C., & de Bartolomeis, A., (2021). Psychological distress in patients with serious mental illness during the COVID-19 outbreak and one-month mass quarantine in Italy. Psychological Medicine, 51(6), 1054–1056. https://doi.org/10.1017/S0033291720001841
  • Jané-Llopis, E., & Matytsina, I. (2006). Mental health and alcohol, drugs and tobacco: A review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug and Alcohol Review, 25(6), 515–536. https://doi.org/10.1080/09595230600944461
  • Jones, C. M., & McCance-Katz, E. F. (2019). Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug and Alcohol Dependence, 197, 78–82. https://doi.org/10.1016/J.DRUGALCDEP.2018.12.030
  • Kandel, D. (1975). Stages in adolescent involvement in drug use. Science, 190(4217), 912–914. https://doi.org/10.1126/science.1188374
  • Khan, S., Okuda, M., Hasin, D. S., Secades-Villa, R., Keyes, K., Lin, K.-H., Grant, B., & Blanco, C. (2013). Gender differences in lifetime alcohol dependence: Results from the national epidemiologic survey on alcohol and related conditions. Alcoholism, Clinical and Experimental Research, 37(10), 1696–1705. https://doi.org/10.1111/ACER.12158
  • Koskinen, J., Löhönen, J., Koponen, H., Isohanni, M., & Miettunen, J. (2009). Prevalence of alcohol use disorders in schizophrenia–A systematic review and meta-analysis. Acta Psychiatrica Scandinavica, 120(2), 85–96. https://doi.org/10.1111/J.1600-0447.2009.01385.X
  • Koura, S., White, A., Masdon, J., Brewer, K. L., Parker-Cote, J. L., & Meggs, W. J. (2023). Retrospective chart review of substance abuse in patients with psychiatric emergencies in an emerging urban county. Journal of the American College of Emergency Physicians Open, 4(4), e13028. https://doi.org/10.1002/emp2.13028
  • Lambert-Harris, C., Saunders, E. C., McGovern, M. P., & Xie, H. (2013). Organizational capacity to address co-occurring substance use and psychiatric disorders: Assessing variation by level of care. Journal of Addiction Medicine, 7(1), 25–32. https://doi.org/10.1097/ADM.0B013E318276E7A4
  • La Rosa, V. L., Gori, A., Faraci, P., Vicario, C. M., & Craparo, G. (2022). Traumatic distress, alexithymia, dissociation, and risk of addiction during the first wave of COVID-19 in Italy: Results from a cross-sectional online survey on a non-clinical adult sample. International Journal of Mental Health and Addiction, 20(5), 3128–3144. https://doi.org/10.1007/s11469-021-00569-0
  • Levit, J. D., Meyers, J. L., Georgakopoulos, P., & Pato, M. T. (2023). Risk for alcohol use problems in severe mental illness: Interactions with sex and racial/ethnic minority status. Journal of Affective Disorders, 325, 329–336. https://doi.org/10.1016/j.jad.2022.12.140
  • Lynskey, M. T., Kimber, J., & Strang, J. (2015). Drug-related mortality in psychiatric patients. The Lancet. Psychiatry, 2(9), 767–769. https://doi.org/10.1016/S2215-0366(15)00372-7
  • McCabe, S. E., Hughes, T. L., West, B. T., Evans-Polce, R. J., Veliz, P. T., Dickinson, K., McCabe, V. V., & Boyd, C. J. (2020). Sexual orientation, adverse childhood experiences, and comorbid DSM-5 substance use and mental health disorders. The Journal of Clinical Psychiatry, 81(6), 20m13291. https://doi.org/10.4088/JCP.20m13291
  • Muruganandam, P., Neelamegam, S., Menon, V., Alexander, J., & Chaturvedi, S. K. (2020). COVID-19 and severe mental illness: Impact on patients and its relation with their awareness about COVID-19. Psychiatry Research, 291, 113265. https://doi.org/10.1016/J.PSYCHRES.2020.113265
  • Peltier, M. R., Roberts, W., Verplaetse, T. L., Zakiniaeiz, Y., Burke, C., Moore, K. E., & McKee, S. A. (2022). Sex differences across retrospective transitions in posttraumatic stress and substance use disorders. Journal of Dual Diagnosis, 18(1), 11–20. https://doi.org/10.1080/15504263.2021.2016027
  • Plana-Ripoll, O., Pedersen, C. B., Holtz, Y., Benros, M. E., Dalsgaard, S., de Jonge, P., Fan, C. C., Degenhardt, L., Ganna, A., Greve, A. N., Gunn, J., Iburg, K. M., Kessing, L. V., Lee, B. K., Lim, C. C. W., Mors, O., Nordentoft, M., Prior, A., Roest, A. M., … McGrath, J. J. (2019). Exploring comorbidity within mental disorders among a Danish national population. JAMA Psychiatry, 76(3), 259–270. https://doi.org/10.1001/JAMAPSYCHIATRY.2018.3658
  • Rash, C. J., Coffey, S. F., Baschnagel, J. S., Drobes, D. J., & Saladin, M. E. (2008). Psychometric properties of the IES-R in traumatized substance dependent individuals with and without PTSD. Addictive Behaviors, 33(8), 1039–1047. https://doi.org/10.1016/j.addbeh.2008.04.006
  • Roberts, A., Rogers, J., Mason, R., Siriwardena, A. N., Hogue, T., Whitley, G. A., & Law, G. R. (2021). Alcohol and other substance use during the COVID-19 pandemic: A systematic review. Drug and Alcohol Dependence, 229(Pt A), 109150. https://doi.org/10.1016/J.DRUGALCDEP.2021.109150
  • Rudenstine, S., Espinosa, A., & Kumar, A. (2020). Depression and anxiety subgroups across alcohol use disorder and substance use in a national epidemiologic study. Journal of Dual Diagnosis, 16(3), 299–311. https://doi.org/10.1080/15504263.2020.1784498
  • Saladin, M. E., Drobes, D. J., Coffey, S. F., Dansky, B. S., Brady, K. T., & Kilpatrick, D. G. (2003). PTSD symptom severity as a predictor of cue-elicited drug craving in victims of violent crime. Addictive Behaviors, 28(9), 1611–1629. https://doi.org/10.1016/j.addbeh.2003.08.037
  • Santucci, K. (2012). Psychiatric disease and drug abuse. Current Opinion in Pediatrics, 24(2), 233–237. https://doi.org/10.1097/MOP.0B013E3283504FBF
  • Schneider, U., Altmann, A., Baumann, M., Bernzen, J., Bertz, B., Bimber, U., Broese, T., Broocks, A., Burtscheidt, W., Cimander, K. F., Degkwitz, P., Driessen, M., Ehrenreich, H., Fischbach, E., Folkerts, H., Frank, H., Gurth, D., Havemann-Reinecke, U., Heber, W., … Wittfoot, J. (2001). Comorbid anxiety and affective disorder in alcohol-dependent patients seeking treatment: The first multicentre study in Germany. Alcohol and Alcoholism, 36(3), 219–223. https://doi.org/10.1093/ALCALC/36.3.219
  • Sheehan, D. V., Lecrubier, Y., Sheehan, K. H., Amorim, P., Janavs, J., Weiller, E., Hergueta, T., Baker, R., & Dunbar, G. C. (1998). The mini-international neuropsychiatric interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry, 59 (Suppl 20), 22–57.
  • Shepherd, A., Sanders, C., Doyle, M., & Shaw, J. (2016). Personal recovery in personality disorder: Systematic review and meta-synthesis of qualitative methods studies. The International Journal of Social Psychiatry, 62(1), 41–50. https://doi.org/10.1177/0020764015589133
  • Stephen Rich, J., & Martin, P. R. (2014). Co-occurring psychiatric disorders and alcoholism. Handbook of Clinical Neurology, 125, 573–588. https://doi.org/10.1016/B978-0-444-62619-6.00033-1
  • Temmingh, H. S., Williams, T., Siegfried, N., & Stein, D. J. (2018). Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse. The Cochrane Database of Systematic Reviews, 1(1), CD011057. https://doi.org/10.1002/14651858.CD011057.PUB2
  • Turner, S., Mota, N., Bolton, J., & Sareen, J. (2018). Self-medication with alcohol or drugs for mood and anxiety disorders: A narrative review of the epidemiological literature. Depression and Anxiety, 35(9), 851–860. https://doi.org/10.1002/DA.22771
  • UNODC. (2021). World Drug Report 2021. https://www.unodc.org/unodc/data-and-analysis/wdr2021.html
  • Virtanen, S., Kuja-Halkola, R., Mataix-Cols, D., Jayaram-Lindström, N., D'Onofrio, B. M., Larsson, H., Rück, C., Suvisaari, J., Lichtenstein, P., & Latvala, A. (2020). Comorbidity of substance misuse with anxiety-related and depressive disorders: A genetically informative population study of 3 million individuals in Sweden. Psychological Medicine, 50(10), 1706–1715. https://doi.org/10.1017/S0033291719001788
  • Wang, P. S., Lane, M., Olfson, M., Pincus, H. A., Wells, K. B., & Kessler, R. C. (2005). Twelve-month use of mental health services in the United States: Results from the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 629–640. https://doi.org/10.1001/ARCHPSYC.62.6.629
  • Waxmonsky, J. A., Thomas, M. R., Miklowitz, D. J., Allen, M. H., Wisniewski, S. R., Zhang, H., Ostacher, M. J., & Fossey, M. D. (2005). Prevalence and correlates of tobacco use in bipolar disorder: Data from the first 2000 participants in the Systematic Treatment Enhancement Program. General Hospital Psychiatry, 27(5), 321–328. https://doi.org/10.1016/j.genhosppsych.2005.05.003
  • Weaver, T., Madden, P., Charles, V., Stimson, G., Renton, A., Tyrer, P., Barnes, T., Bench, C., Middleton, H., Wright, N., Paterson, S., Shanahan, W., Seivewright, N., & Ford, C, (2003). Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. The British Journal of Psychiatry: The Journal of Mental Science, 183(4), 304–313. https://doi.org/10.1192/BJP.183.4.304
  • Weiss, D. S., & Marmar, C. R. (1997). The impact of event scale – revised. In J. P. Wilson & T. M. Keane (Eds.), Assessing Psychological Trauma and PTSD (pp. 399–411). Guilford Press.
  • Wise, B. K., Cuffe, S. P., & Fischer, T. (2001). Dual diagnosis and successful participation of adolescents in substance abuse treatment. Journal of Substance Abuse Treatment, 21(3), 161–165. https://doi.org/10.1016/s0740-5472(01)00193-3
  • Young, J. T., Heffernan, E., Borschmann, R., Ogloff, J. R. P., Spittal, M. J., Kouyoumdjian, F. G., Preen, D. B., Butler, A., Brophy, L., Crilly, J., & Kinner, S. A. (2018). Dual diagnosis of mental illness and substance use disorder and injury in adults recently released from prison: A prospective cohort study. The Lancet Public Health, 3(5), e237–e248. https://doi.org/10.1016/S2468-2667(18)30052-5

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.